Meet Alice & Brian - Case Studies of Specialty Drug Costs A closer look at the data and the stories of patients paints a more complicated picture
Important Caveats: This observation is anecdotal, not registry-derived It is not a substitute for controlled epidemiology It provides real-world context consistent with MTC rarity and absence of compelling causal signals in highest-quality human evidence Clinical Significance: In a practice seeing more thyroid cancer than anywhere globally, we are not observing an MTC wave in GLP-1 users
We found that the cell viability was reduced by no more than 10% by 50 M WL-1 in all cell lines, which suggested that WL-1 did not exert toxic effects on cells up to 50 M concentration
Accumulated evidence suggests that ROS function as second messengers in the determination of cell fate and the modification of various signaling molecules [41]
Similar Efficacy and Gastrointestinal Tolerability Versus Exposure for Oral and Subcutaneous Semaglutide, in: The 55th Annual Meeting of the European Association for the Study of Diabetes (EASD Virtual Meeting), Abstract #777
At 0.25mg weekly versus 2.4mg, you are using roughly 10% of the standard dose